All Posts

Aneuploidy selects for the acquisition of driver genes in breast cancer | Nature Article

The lab of Daniel Schramek published another important paper leveraging GEMM Models for elucidating cancer biology and mapped out drivers with therapeutical potential of TNBC. https://www.nature.com/articles/s41586-026-10752-9

Aug 14

ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets

ViVerita Therapeutics today announced a strategic research collaboration with Boehringer Ingelheim aimed at accelerating the discovery...

May 7, 2025

CRISPR-StAR to transform in vivo functional genomic screening | Nature Reviews Cancer

Exciting news! Nature Reviews Cancer and Christopher Lowden published a very insightful article on the power of CRISPR-StAR to transform...

Apr 16, 2025

Tackling in vivo screening complexity

Nature Methods highlights CRISPR-StAR, the proprietary CRISPR-screening technology of ViVerita. https://www.nature.com/articles/s41592-02...

Feb 11, 2025

ViVerita Therapeutics licenses CRISPR-StAR patent from IMBA

ViVerita announces to having executed a licensing deal for CRISPR-StAR and CRISPR-Switch, two proprietary technologies developed by...

Jan 8, 2025

CRISPR-StAR, ViVeritas game-changing technology for in vivo screening published at Nature Biotechnology

The proprietary technology to empower high resolution in vivo CRISPR screening was published in Nature biotechnology. This method,...

Dec 16, 2024